926
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

Zinc in dermatology

, ORCID Icon &
Pages 2455-2458 | Received 03 Feb 2022, Accepted 30 Mar 2022, Published online: 18 Apr 2022

References

  • Gupta M, Mahajan VK, Mehta KS, et al. Zinc therapy in dermatology: a review. Dermatol Res Pract. 2014;2014:709152.
  • Yee BE, Richards P, Sui JY, et al. Serum zinc levels and efficacy of zinc treatment in acne vulgaris: a systematic review and Meta-analysis. Dermatol Ther. 2020;33(6):e14252.
  • Chan H, Chan G, Santos J, et al. A randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of lactoferrin with vitamin E and zinc as an oral therapy for mild to moderate acne vulgaris. Int J Dermatol. 2017;56(6):686–690.
  • Hillström L, Pettersson L, Hellbe L, et al. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol. 1977;97(6):681–684.
  • Göransson K, Lidén S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol. 1978;58(5):443–448.
  • Cunliffe WJ, Burke B, Dodman B, et al. A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris. Br J Dermatol. 1979;101(3):321–325.
  • Dreno B, Moyse D, Alirezai M, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203(2):135–140.
  • Michaëlsson G, Juhlin L, Ljunghall K. A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol. 1977;97(5):561–566.
  • Dhaliwal S, Nguyen M, Vaughn AR, et al. Effects of zinc supplementation on inflammatory skin diseases: a systematic review of the clinical evidence. Am J Clin Dermatol. 2020;21(1):21–39.
  • Sitohang IBS, Yahya YF, Simanungkalit R, et al. Efficacy and tolerability of topical nicotinamide plus antibacterial adhesive agents and Zinc-Pyrrolidone carboxylic acid versus placebo as an adjuvant treatment for moderate acne vulgaris in Indonesia: a multicenter, double-blind, randomized, controlled trial. J Clin Aesthet Dermatol. 2020;13(7):27–31.
  • Sayyafan MS, Ramzi M, Salmanpour R. Clinical assessment of topical erythromycin gel with and without zinc acetate for treating mild-to-moderate acne vulgaris. J Dermatolog Treat. 2020;31(7):730–733.
  • Kahvaz MS, Soltani S, Soltani S, et al. Low serum levels of selenium, zinc, iron, and zinc/copper ratio in an endemic region of cutaneous leishmaniasis in southwest Iran. Biol Trace Elem Res. 2021;199(4):1291–1296.
  • Taghipour A, Abdoli A, Ramezani A, et al. Leishmaniasis and trace element alterations: a systematic review. Biol Trace Elem Res. 2021;199(10):3918–3938. [epub ahead of print].
  • Sharquie KE, Najim RA, Farjou IB. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol. 1997;22(4):169–173.
  • Maleki M, Karimi G, Tafaghodi M, et al. Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis. Indian J Dermatol. 2012;57(2):118–122.
  • Firooz A, Khatami A, Khamesipour A, et al. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial. J Drugs Dermatol. 2005;4(1):73–79.
  • Sharquie K, Noaimi A, Sharara Z, et al. Topical therapy of acute cutaneous leishmaniasis using zinc sulphate solution 25% versus podophyllin solution 25%. JCDSA. 2017;07(03):258–274.
  • Carbone DCB, Zanoni LZG, Cônsolo FZ, et al. Potential role of zinc in the visceromegaly regression and recovery of hematological parameters during treatment of visceral leishmaniasis in children from an endemic area. Rev Inst Med Trop Sao Paulo. 2018;60:e50.
  • El-Komy M, Hafez V, Hay RA, et al. Toenail concentrations of zinc, selenium and nickel in patients with chronic recurrent warts: a pilot two-group comparative study. Indian J Dermatol Venereol Leprol. 2019;85(1):51–55.
  • Songsantiphap C, Asawanonda P. Topical 15% zinc oxide ointment significantly reduces the size of common warts after four weeks: a randomized, triple-blinded, placebo-controlled trial. J Clin Aesthet Dermatol. 2019;12(9):26–31.
  • El Sayed MH, Sayed FS, Afify AA. Intralesional zinc sulfate 2% vs intralesional vitamin D in plantar warts: a clinicodermoscopic study. Dermatol Ther. 2020;33(3):e13308.
  • Abd El-Magid WM, Nada EEA, Mossa RA. Intralesional injection of vitamin D3 versus zinc sulfate 2% in treatment of plantar warts: a comparative study. J Dermatolog Treat. 2019;29:1–6.
  • Janniger CK, Schwartz RA. Efficacy and tolerability of a new topical nitric-zinc preparation for "difficult-to-treat" warts. Dermatol Ther. 2017;30(2):e12456.
  • Rozas-Muñoz E, Mir-Bonafé J, Piquero-Casals J. Refractory warts successfully treated with a nitric-zinc complex solution. J Dermatol. 2019;46(7):e250–e251.
  • Giacaman A, Granger C, Aladren S, et al. Use of topical nitric-zinc complex solution to treat palmoplantar and periungual warts in a pediatric population. Dermatol Ther (Heidelb). 2019;9(4):755–760.
  • Puviani M, Manfredini M, Eisendle K. The SILVER study. Efficacy of topical nitric-zinc complex solution in the treatment of resistant warts: a postmarketing evaluation. Dermatol Ther. 2019;32(4):e12940.
  • Poveda I, Vilarrasa E, Martorell A, et al. Serum zinc levels in hidradenitis suppurativa: a case-control study. Am J Clin Dermatol. 2018; 19(5):771–777.
  • Hessam S, Sand M, Meier NM, et al. Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa. J Dermatol Sci. 2016;84(2):197–202.
  • Molinelli E, Brisigotti V, Campanati A, et al. Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: a controlled retrospective clinical study. J Am Acad Dermatol. 2020;83(2):665–667.
  • Brocard A, Knol AC, Khammari A, et al. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology. 2007; 214(4):325–327.
  • Kil MS, Kim CW, Kim SS. Analysis of serum zinc and copper concentrations in hair loss. Ann Dermatol. 2013; 25(4):405–409.
  • El‐Esawy FM, Hussein MS, Ibrahim Mansour A. Serum biotin and zinc in male androgenetic alopecia. J Cosmet Dermatol. 2019;18(5):1546–1549.
  • Berger RS, Fu JL, Smiles KA, et al. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial. Br J Dermatol. 2003;149(2):354–362.
  • Siavash M, Tavakoli F, Mokhtari F. Comparing the effects of zinc sulfate, calcium pantothenate, their combination and minoxidil solution regimens on controlling hair loss in women: a randomized controlled trial. J Res Pharm Pract. 2017;6(2):89–93.
  • Park H, Kim CW, Kim SS, et al. The therapeutic effect and the changed serum zinc level after zinc supplementation in alopecia areata patients who had a low serum zinc level. Ann Dermatol. 2009;21(2):142–146.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.